PharmaCyte Biotech, Inc. 13D and 13G filings for Femasys Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-22 4:00 pm Purchase |
2023-11-14 | 13D | Femasys Inc. FEMY |
PharmaCyte Biotech Inc. PMCB |
12,711,864 37.000% |
12,711,864 (New Position) |
Filing |